Scientists identify promising new target to combat Alzheimer’s disease
New research is the first to link maladaptive changes in calcium transport by mitochondria to the progression of Alzheimer's disease.
List view / Grid view
New research is the first to link maladaptive changes in calcium transport by mitochondria to the progression of Alzheimer's disease.
Scientists combine organ-on-a-chip and stem-cell technologies to make a powerful tool for diabetes research.
Scientists have shown that drug-resistant bacteria infections shut out antibiotics by closing tiny doors in their cell walls.
Breast cancer medicines may force some cancer cells into 'sleeper mode', allowing them to potentially come back to life after treatment.
It has been discovered that Id4 controls whether stem cells enter cell division and may be relevant for treating neurodegenerative disease.
Using new technology researchers have shown that sick mitochondria pollute the cells they are supposed to be supplying with power.
There is an increasing need to expand the variety and complexity of cell-based assays for biological research and drug discovery.
TSKgel FcR-IIIA-NPR is based on a recombinant FcγIIIa receptor ligand immobilized on a non-porous polymer particle. It allows fast assessment of biologic activity of monoclonal antibodies.
Researchers may have fundamentally altered the way scientists study brain diseases with new CRISPR technology.
Researchers have discovered that removing the enzyme, PHLPP1, improves outcomes in a mouse model of sepsis so could be a potential drug target.
It has been discovered that Polo-like kinase (PLK1) guards against severe DNA damage and could help target fast-growing cancer cells.
New study shows that a subset of follicular helper T cells contributes to the hyposialylation of autoantibodies in rheumatoid arthritis.
Researchers have newly found that protein CD24 acts as a defensive signal and is used by cancer cells to protect themselves.
A new study has shown that proteins derived from the oncogene, KRAS, can transfer between colon cancer cells.
Immunohistochemistry (IHC) and immunocytochemistry (ICC) are techniques employed to localize antigen expression and are dependent on specific epitope-antibody interactions.